8-K ·Filed Apr 3, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor for any subsequent board appointments or governance changes, particularly given the departure from a key committee. The resignation appears amicable, but the loss of a governance committee member may temporarily affect board dynamics.
Price Chart
Loading chart...
Executive Summary
Ensysce Biosciences, Inc. announced the resignation of board member Dr. Curtis Rosebraugh, effective April 1, 2026. The resignation was not due to any disagreement with the company, and no replacement was named in the filing.
Key Facts
- Dr. Curtis Rosebraugh resigned from the Board of Directors effective April 1, 2026
- Resignation was not due to any disagreement with the company, management, or board
- Dr. Rosebraugh previously served on the Nominating and Corporate Governance Committee
- No replacement was announced in the filing
Financial Impact
No direct financial impact disclosed
Risk Factors
- Potential delay in board committee functions, particularly around nominations and governance
- Possible investor concern if additional board members depart in the near term
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-015139 |
| Exhibit: ex17.htm | 0001493152-26-015139 |
| Document: 0001493152-26-015139-index-headers.html | 0001493152-26-015139 |
| Document: 0001493152-26-015139-index.html | 0001493152-26-015139 |
| Document: 0001493152-26-015139.txt | 0001493152-26-015139 |
5 reports for ENSCW
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 4, 2026 20w ago | S-3 | — | awaiting T+20 | — | — |
May 22, 2026 22w ago | 8-K | — | awaiting T+20 | — | — |
May 15, 2026 23w ago | 8-K | — | awaiting T+20 | — | — |
Apr 3, 2026 29w ago | 8-K | — | awaiting T+20 | — | — |
Mar 30, 2026 30w ago | 8-K | — | awaiting T+20 | — | — |
Showing 5 of 5
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers